Biopsy of the sentinel lymph nodes using indocyanine green fluorescence method in local cutaneous melanoma-Reference-Cited by-同舟云学术

Biopsy of the sentinel lymph nodes using indocyanine green fluorescence method in local cutaneous melanoma

Published:2023-09-14 Issue:3 Volume:15 Page:16-20
ISSN:2782-3687
Container-title:Bone and soft tissue sarcomas, tumors of the skin
language:
Short-container-title:jour

Author:

Titov K. S.¹^ORCID,Dzhamilov Sh. R.²^ORCID,Lebedinsky I. N.²^ORCID,Sukhotko A. S.²^ORCID,Evsikov A. I.²^ORCID,Sorokina M. V.²^ORCID,Zapirov G. M.³^ORCID,Grekov D. N.⁴^ORCID

Affiliation:

1. S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department; Peoples’ Friendship University of Russia

2. S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department

3. Peoples’ Friendship University of Russia; P.A. Herzen Moscow Research Oncological Institute – branch of the National Medical Research Center of Radiology, Ministry of Health of Russia

4. S.P. Botkin City Clinical Hospital of the Moscow Healthcare Department; Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

Abstract

Timely diagnosis and treatment of cutaneous melanoma are important problems as mortality for this pathology exceeds 70 % of all skin tumors, and in Russia this disease is diagnosed at stage I only in 35.7 % of cases. Correctly selected therapy offers good results, but effective treatment requires accurate staging involving detection of metastases in the sentinel lymph nodes which cannot be identified clinically. This review analyzes study data showing the effectiveness of detection of the sentinel lymph nodes using indocyanine green fluorescence method.

Publisher

Publishing House ABV Press

Reference37 articles.

1. Malignant neoplasms in Russia in 2013 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2015. (In Russ.).

2. Malignant neoplasms in Russia in 2015 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G. V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2017. (In Russ.).

3. Malignant neoplasms in Russia in 2017 (morbidity and mortality). Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2018. (In Russ.).

4. Malignant neoplasms in Russia in 2020 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: P.A. Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution “P.A. Herzen NMIRC” of the Ministry of Health of Russia, 2021. 252 p. (In Russ.).

5. Petrova G.V., Kaprin A.D., Gretsova O.P., Starinsky V.V. Malignant neoplasms in Russia. Review of statistical information for 1993–2013. General ed. by A.D. Kaprin, V.V. Starinsky. Moscow, 2015. Pp. 306–339. (In Russ.).